African Institute of Biomedical Science & Technology
- Molecular Sciences
- Medicinal Chemistry
- Clinical Sciences
- Pharmaceutics and Drug Manufacturing
- Bioanalytical Chemistry
The African Institute of Biomedical Science & Technology, AiBST, was established in 2002 with the aim to strengthen African’s scientific & technical capacity to contribute to healthcare solutions for its people.
It is a private not-for-profit research and education institute which is registered with the Ministry of Higher & Tertiary Education and works closely with the Ministry of Health & Child Welfare and the Ministry of Science Technology Development
Research & Development
AiBST has established state-of-the-art laboratories in Zimbabwe. Research at AiBST aims at drug discovery, development and optimal clinical use of medicines.
It is the WHO-TDR and the African Network for Drugs and Diagnostics Innovation (ANDi) CoE in DMPK and Toxicology. It is also a leading centre for pharmacogenomic studies and is the leader of the African Pharmaco- genomics Consortium
and Continuing Professional Biomedical
To increase the skilled human resource base for cutting edge biomedical science & technology, AiBST has a postgraduate (MSc & PhD) training program which attracts many young scientists from across Africa.
It also conducts advanced biomedical courses for both postgraduate students and professionals to encourage adoption of best and current technologies & practices in institutions of life sciences.
In a bid to promote lab-bench to patient-bedside or product on the market biomedical R&D, AiBST has a biomedical entrepreneurship unit.In this unit biomedical businesses are incubated with the idea to finally wean them off as private independent companies.
Current business incubations include Molecular Diagnostics, Drug Discovery ADMET/PK Services, & Distribution of Biomedical Reagents for Drug Discovery Research.
- AiBST selected as an ANDi Centre of Excellnce in DMPK and Toxicology for drug discovery & development. 25 October 2011
- South African students, two from North-West University and two from University of Cape Town came for metabolism research & training attachment at AiBST. July to November 2011
- AiBST moves into new premises. June 2011
- New logo & new website look!
LATEST RESEARCH PUBLICATIONS
- Maimbo M, Kiyotani K, Mushiroda T, Masimirembwa C, Nakamura Y. CYP2B6 genotype is a strong predictor of systemic exposure to efavirenz in HIV-infected Zimbabweans. Eur J Clin Pharmacol. 2011 Sep 8. PMID:21901344
- Kelly Chibale, Eric Guantai & Collen Masimirembwa. Extracting molecular information from African natural products to facilitate unique African-led drug-discovery efforts. Future Med. Chem. (2011) 3(3), 257–261.